Point-of-care rapid test for SARS-CoV-2 detection suitable for home-based testing. Delivers results quickly to support early identification and isolation decisions. Reduces need for centralized laboratory processing.
Manufactured by
Exactics, Inc.
United States
Exactics develops and manufactures at-home rapid diagnostic testing solutions for infectious diseases. The company specializes in point-of-care testing technology designed for consumer use, enabling patients to perform quick and reliable disease detection outside traditional clinical settings. Exactics' product portfolio focuses on making rapid diagnostics accessible and convenient for home-based healthcare monitoring.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Zhejiang Sorfa Life Science Research Co., Ltd
China · 2 relevant products
PROFICIENT MEDITECH SDN BHD
Malaysia · 2 relevant products
Genrui Biotech Inc.
China · 1 relevant product
89 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →22 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 111 closest product alternatives
Zhejiang Sorfa Life Science Research Co., Ltd · China
Point-of-care antigen detection tests for SARS-CoV-2 identification from nasopharyngeal or oropharyngeal samples. These rapid tests provide results within 15-30 minutes and are suitable for clinical and field testing environments.
PROFICIENT MEDITECH SDN BHD · Malaysia
Point-of-care rapid antigen test kits for quick COVID-19 detection in clinical settings. Enables fast diagnosis to support infection control and patient management decisions.
Genrui Biotech Inc. · China
Rapid diagnostic test for qualitative detection of SARS-CoV-2 antigen or serology markers. Available in serological and antigen formats for point-of-care testing applications.
108 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products